Mednet Logo
HomeHematologyQuestion

Would you combine sutimlimab with bendamustine rituximab for cold agglutinin disease if patient continues to hemolyze during treatment?

1 Answers
Mednet Member
Mednet Member
Medical Oncology · UPMC Hillman Cancer Center

In my experience, virtually all patients with true cold agglutinin disease respond to sutimlimab quite quickly. While there may be sub-clinical evidence of hemolysis for some time, generally hemoglobin improves to normal or close to this. Adding therapy to sutimlimab really depends upon the clinical...

Register or Sign In to see full answer

Would you combine sutimlimab with bendamustine rituximab for cold agglutinin disease if patient continues to hemolyze during treatment? | Mednet